BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6202124)

  • 21. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 24. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase.
    Fredholm BB; Hedqvist P; Vernet L
    Biochem Pharmacol; 1978; 27(24):2845-50. PubMed ID: 216371
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
    Mohindru A; Chenet A; Rhoads AR
    Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth.
    Dumas MY; Fanidi A; Pageaux JF; Courion C; Nemoz G; Prigent AF; Pacheco H; Laugier C
    Endocrinology; 1988 Jan; 122(1):165-72. PubMed ID: 2446855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
    Singh R; Shankar R
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
    [No Abstract]   [Full Text] [Related]  

  • 31. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 33. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
    Rybalkin SD; Sobolev AS
    Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
    Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
    Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
    [No Abstract]   [Full Text] [Related]  

  • 36. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings].
    Saeed SA; Butt NM; Taylor WA
    Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cyclic nucleotide phosphodiesterase from wheat sprouts. Purification, properties, effect of systemic fungicides].
    Igumenov BL; Etingof RN
    Biokhimiia; 1980 Oct; 45(10):1797-803. PubMed ID: 6263360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts.
    Takemoto DJ; Lee WN; Kaplan SA; Appleman MM
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.